GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » EV-to-FCF

Japan Tissue Engineering Co (TSE:7774) EV-to-FCF : (As of Apr. 01, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Japan Tissue Engineering Co's Enterprise Value is 円14,292 Mil. Japan Tissue Engineering Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was 円0 Mil. Therefore, Japan Tissue Engineering Co's EV-to-FCF for today is .

The historical rank and industry rank for Japan Tissue Engineering Co's EV-to-FCF or its related term are showing as below:

TSE:7774' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 15756.63
Current: 15756.63

During the past 13 years, the highest EV-to-FCF of Japan Tissue Engineering Co was 15756.63. The lowest was 0.00. And the median was 0.00.

TSE:7774's EV-to-FCF is ranked worse than
99.77% of 433 companies
in the Biotechnology industry
Industry Median: 3.34 vs TSE:7774: 15756.63

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-01), Japan Tissue Engineering Co's stock price is 円457.00. Japan Tissue Engineering Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was 円3.522. Therefore, Japan Tissue Engineering Co's PE Ratio (TTM) for today is 129.76.


Japan Tissue Engineering Co EV-to-FCF Historical Data

The historical data trend for Japan Tissue Engineering Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Japan Tissue Engineering Co EV-to-FCF Chart

Japan Tissue Engineering Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -100.35 -53.56 -46.43 -21.32 24,415.51

Japan Tissue Engineering Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 24,415.51 -

Competitive Comparison of Japan Tissue Engineering Co's EV-to-FCF

For the Biotechnology subindustry, Japan Tissue Engineering Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Japan Tissue Engineering Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Japan Tissue Engineering Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Japan Tissue Engineering Co's EV-to-FCF falls into.


;
;

Japan Tissue Engineering Co EV-to-FCF Calculation

Japan Tissue Engineering Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=14292.403/0
=

Japan Tissue Engineering Co's current Enterprise Value is 円14,292 Mil.
Japan Tissue Engineering Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Japan Tissue Engineering Co  (TSE:7774) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Japan Tissue Engineering Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=457.00/3.522
=129.76

Japan Tissue Engineering Co's share price for today is 円457.00.
Japan Tissue Engineering Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3.522.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Japan Tissue Engineering Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Japan Tissue Engineering Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Japan Tissue Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Japan Tissue Engineering Co Headlines

No Headlines